Skip to content

Solesence, Inc. Common Stock SLSN Q4 2025 Annual earnings

Reported March 31, 2026 · Before market open

Next report

Aug 6, 2026 (In 3 weeks)

Financials

Q4 2025

Income statement

See full
Revenue$12.5M-0.7%
Gross profit$3.4M+24.2%
Operating income$186.0K
Net income$163.0K
EPS (diluted)$0.00

Balance sheet

See full
Cash & equivalents$1.3M-8.6%
Total debt$10.1M-2.4%
Total equity$17.6M+18.0%
Total assets$50.1M+0.1%

Cash flow

See full
CapEx$450.0K-82.6%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$112.51M
Enterprise value$121.27M
P/E62.9×
P/S1.8×

Profitability

See full
Gross margin25.9%-5.0pp
Operating margin2.5%-7.7pp
Net margin2.9%

Returns & leverage

See full
Return on equity11%
Debt / equity0.6×-0.1×
Current ratio2.1×+0.9×

Segments

By product

See full
Consumer Products$10.5M-8.4%
Personal Care Ingredients$1.9M+120%
Advanced Materials$89.0K-62.4%

By geography

See full
Non Us$1.0K-99.7%

Versus estimates

Ask the moment Solesence, Inc. Common Stock reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Solesence, Inc. Common Stock report Q4 2025 earnings?
Solesence, Inc. Common Stock (SLSN) reported Q4 2025 earnings on March 31, 2026 before market open.
What were Solesence, Inc. Common Stock's Q4 2025 revenue and EPS?
Solesence, Inc. Common Stock reported revenue of $12.5M and diluted EPS of $0.00 for Q4 2025.
How did Solesence, Inc. Common Stock's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 0.7% from $12.6M a year earlier.
Where can I find Solesence, Inc. Common Stock's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001171843-26-002061) and the 10-K periodic report (0001999371-26-007345) directly on SEC EDGAR. The filing index links above go to sec.gov.